Sfoglia per AUTORE
BIANCHI B
Collezione AOU Alessandria

  

Items : 3

Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma. in Blood advances / Blood Adv. 2026 Jun 25:bloodadvances.2025018732. doi: 10.1182/bloodadvances.2025018732.
2026
AOU Alessandria

Botto B; Boccomini C; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Rusconi C; Bari A; Del Giudice I; Gaidano G; Spina M; Maschio N; Castellino C; Rota-Scalabrini D; Puccini B; Arcari A; Bigliardi S; Matta GME; Bianchi B; Mannina D; Marino D; Galieni P; Ciambelli F; et alii...

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial. in Blood advances / Blood Adv. 2026 Jul 24:bloodadvances.2026020780. doi: 10.1182/bloodadvances.2026020780.
2026
AOU Alessandria

Moia R; Almasri M; Carazzolo ME; Cividini L; Tabanelli V; Melle F; Genuardi E; Cosentino C; Maher N; Bellia M; Mahmoud AM; Evangelista A; Quaglia FM; Fiori S; Bomben R; Tisi MC; Riva M; Merli A; Di Rotondo F; Corradini P; Farina L; Castellino C; Castellino A; Zilioli VR; Muzi C; Piazza F; Re A; Hohaus S; Rossi Dardanoni FG; et alii...

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma
2024
AOU Alessandria
AO Cuneo

Usai SV; Vitolo U; Falcinelli F; Gini G; Galimberti S; Roti G; Mannina D; Musto P; Conconi A; Massaia M; Bari A; Califano C; Arcari A; Chiarenza A; Pavone V; Bolis SAM; Bianchi B; Tosi P; Musuraca G; Ladetto M; Barbieri E; Monaco L; Franceschetto A; Peano S; Durmo R; Marcheselli L; Bergesio F; Fallanca F; Chauvie S; et alii...